The Embyr Discovery Engine
A comprehensive platform integrating:
knowledge graphs, deep probabilistic analysis models, AI algorithms, and a modular CRISPR toolkit.
purpose-built to solve drug discovery's hardest problems.
Single-Cell & Spatial Technologies
Disease biology happens at the cellular level. Our single-cell and spatial transcriptomic capabilities reveal the heterogeneity that bulk methods miss—identifying the specific cell populations driving disease, responding to treatment, or causing adverse effects.
Perturb-seq
Test hundreds of genetic perturbations simultaneously with single-cell resolution. Our modular CRISPR platform enables knockout, knockdown, activation, and base editing—all in a single parallel experiment. The result: functional validation data that compresses discovery timelines
Multi-Omics Integration
No single data type tells the whole story. We integrate transcriptomic, proteomic, and phenotypic data into unified analyses, connecting genetic perturbations to molecular mechanisms to cellular outcomes.
AI/ML Analysis
Our probabilistic models and knowledge graphs don't just analyze data—they generate hypotheses. By integrating public databases, proprietary datasets, and experiment results, our AI identifies patterns that support target prioritization.
